Mark Andermann, Ph.D., opened his laboratory in the Division of Endocrinology, Diabetes, and Metabolism at Beth Israel Deaconess Medical Center (BIDMC) in 2012. Dr. Andermann graduated from McGill University in 1999 with a joint honors degree in mathematics and physics, and trained with Dr. Christopher Moore during his Ph.D. at MIT and Harvard University. Dr. Andermann completed his postdoctoral training with Dr. Clay Reid at Harvard Medical School, where he developed new tools for studying the neural basis of visual perception using calcium imaging in behaving mice. Dr. Andermann’s lab uses these tools to study visual processing in retina, thalamus, cortex, and amygdala, and to understand how hunger biases visual processing towards food cues. These efforts should facilitate development of more targeted therapies that address both genetic and environmental contributions to obesity, anorexia nervosa, and other eating disorders. This has been supported, in part, by a Pew Scholars Award, a Smith Family Foundation Award, a McKnight Scholar Award, and a Director’s New Innovator Award from the National Institutes of Health.